Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
FDA Launches Safety Study of Abortion Pill Mifepristone
00

FDA Launches Safety Study of Abortion Pill Mifepristone

Jun 5, 2026

The Food and Drug Administration has launched a safety study of mifepristone, the abortion pill approved decades ago, marking a victory for antiabortion groups and Republican members of Congress who demanded action from the Trump administration. The FDA's website currently states mifepristone is safe to use as indicated. The study could pave the way for restrictions on how the drug is distributed and used.

FDA mifepristone safety study

  • ▪The FDA mifepristone safety study could pave the way for the Trump administration to restrict how mifepristone is distributed and used
  • ▪The Food and Drug Administration has launched a safety study of mifepristone
  • ▪The FDA's website says that mifepristone, approved decades ago, is safe to use as indicated

Antiabortion advocacy efforts

  • ▪Antiabortion allies had lost patience with assurances from Trump administration officials that a mifepristone study would be conducted
  • ▪The FDA mifepristone safety study marks a victory for antiabortion groups and Republican members of Congress
  • ▪Antiabortion groups and Republican members of Congress have demanded action from the Trump administration to crack down on mifepristone's use

Perspective of Antiabortion groups and Republican members of Congress

  • ▪The FDA mifepristone safety study marks a victory for antiabortion groups and Republican members of Congress
  • ▪The FDA mifepristone safety study could pave the way for the Trump administration to restrict how mifepristone is distributed and used

1 source

The Wall Street Journal
Exclusive | FDA Launches Study of Abortion Pill Safety as Opponents Push for Limits
View source article

Story comments

Loading comments…

Related entities

United States

Related Projects

FDA (Food and Drug Administration)

Topics

Reproductive rightsUS health policy & drug pricingDrug Approval and Clinical TrialsReproductive Health